Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies

Abstract Chimeric antigen receptor (CAR) T cells and natural killer (NK) cells are genetically engineered immune cells that can detect target antigens on the surface of target cells and eliminate them following adoptive transfer. Recent progress in CAR-based therapies has led to outstanding clinical...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hamed Dabiri, Pooria Safarzadeh Kozani, Mahdi Habibi Anbouhi, Mohadeseh Mirzaee Godarzee, Mohammad Hossein Haddadi, Mohsen Basiri, Vahab Ziaei, Majid Sadeghizadeh, Ensiyeh Hajizadeh Saffar
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-07-01
Col·lecció:	Biomarker Research
Matèries:	Chimeric antigen receptor Cancer immunotherapy Genome-editing technologies Retroviral vectors Natural killer cells
Accés en línia:	https://doi.org/10.1186/s40364-023-00509-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!